These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
653 related items for PubMed ID: 17133550
21. Long-term serological follow-up of blood donors with an HTLV-indeterminate western blot: antibody profile of seroconverters and individuals with false reactions. Martins ML, Santos AC, Namen-Lopes MS, Barbosa-Stancioli EF, Utsch DG, Carneiro-Proietti AB. J Med Virol; 2010 Oct; 82(10):1746-53. PubMed ID: 20827773 [Abstract] [Full Text] [Related]
22. Evaluation of HTLV-I/II infection in blood donors in Buenos Aires. Gutfraind Z, Blejer JL, Saguier MC, Gómez Carretero ML, Pirola DA, Carreras Vescio LA. Medicina (B Aires); 1995 Oct; 55(4):295-9. PubMed ID: 8728867 [Abstract] [Full Text] [Related]
23. Enhanced specificity of truncated transmembrane protein for serologic confirmation of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 infections by western blot (immunoblot) assay containing recombinant envelope glycoproteins. Varma M, Rudolph DL, Knuchel M, Switzer WM, Hadlock KG, Velligan M, Chan L, Foung SK, Lal RB. J Clin Microbiol; 1995 Dec; 33(12):3239-44. PubMed ID: 8586709 [Abstract] [Full Text] [Related]
24. Prevalence of human T-cell leukemia virus types I and II in Switzerland. Böni J, Bisset LR, Burckhardt JJ, Joller-Jemelka HI, Bürgisser P, Perrin L, Gorgievski M, Erb P, Fierz W, Piffaretti JC, Schüpbach J, Swiss HIV Cohort Study. J Med Virol; 2004 Feb; 72(2):328-37. PubMed ID: 14695678 [Abstract] [Full Text] [Related]
26. Evidence among blood donors for a 30-year-old epidemic of human T lymphotropic virus type II infection in the United States. Murphy EL, Watanabe K, Nass CC, Ownby H, Williams A, Nemo G. J Infect Dis; 1999 Dec; 180(6):1777-83. PubMed ID: 10558931 [Abstract] [Full Text] [Related]
28. Serological speciation of human T-cell leukaemia virus infections using synthetic peptide antigens. Tosswill JH, McAlpine L, Mortimer PP. J Med Virol; 1993 May; 40(1):83-5. PubMed ID: 8099946 [Abstract] [Full Text] [Related]
29. Neither molecular diversity of the envelope, immunosuppression status, nor proviral load causes indeterminate HTLV western blot profiles in samples from human T-cell lymphotropic virus type 2 (HTLV-2)-infected individuals. Olah I, Fukumori LM, Smid J, de Oliveira AC, Duarte AJ, Casseb J. J Med Virol; 2010 May; 82(5):837-42. PubMed ID: 20336719 [Abstract] [Full Text] [Related]
30. High prevalence of HTLV-I and HTLV-II among blood donors in Argentina: a South American health concern. Biglione MM, Astarloa L, Salomón HE, Referent HTLV-I/II Argentina Group. AIDS Res Hum Retroviruses; 2005 Jan; 21(1):1-4. PubMed ID: 15665638 [Abstract] [Full Text] [Related]
31. Molecular characterization of human T-cell lymphotropic virus type 2 (HTLV-II) from people living in urban areas of Sao Paulo city: evidence of multiple subtypes circulation. Novoa P, Penalva de Oliveira AC, Posada Vergara MP, da Silva Duarte AJ, Casseb J. J Med Virol; 2007 Feb; 79(2):182-7. PubMed ID: 17177305 [Abstract] [Full Text] [Related]
32. HTLV type I and HTLV type II infection among Indians and natives from Argentina. Bouzas MB, Zapiola I, Quiruelas S, Gorvein D, Panzita A, Rey J, Carnese FP, Corral R, Perez C, Zala C. AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1567-71. PubMed ID: 7888211 [Abstract] [Full Text] [Related]
33. Difficulties in the diagnosis of HTLV-2 infection in HIV/AIDS patients from Brazil: comparative performances of serologic and molecular assays, and detection of HTLV-2b subtype. Morimoto HK, Morimoto AA, Reiche EM, Ueda LT, Matsuo T, Reiche FV, Caterino-de-Araujo A. Rev Inst Med Trop Sao Paulo; 2007 Nov; 49(4):225-30. PubMed ID: 17823751 [Abstract] [Full Text] [Related]
34. A seroepidemiological survey of HTLV-I/II carriers in the Puna Jujeña. Dipierri JE, Tajima K, Cartier Robirosa L, Sonoda S. Medicina (B Aires); 1999 Nov; 59(6):717-20. PubMed ID: 10752214 [Abstract] [Full Text] [Related]
35. Low prevalence of antibodies to human T-lymphotropic virus-I/II among blood donors in eastern Saudi Arabia. Fawaz NA, Tamim H, Almawi WY. Am J Infect Control; 2005 Apr; 33(3):189-91. PubMed ID: 15798675 [Abstract] [Full Text] [Related]
36. Confirming the presence of HTLV-1 infection and the absence of HTLV-2 in blood donors from Arequipa, Peru. Quispe NC, Feria EB, Santos-Fortuna Ede L, Caterino-de-Araujo A. Rev Inst Med Trop Sao Paulo; 2009 Apr; 51(1):25-9. PubMed ID: 19229387 [Abstract] [Full Text] [Related]
37. HTLV-I/II infection in a high viral endemic area of Zaire, Central Africa: comparative evaluation of serology, PCR, and significance of indeterminate western blot pattern. Garin B, Gosselin S, de Thé G, Gessain A. J Med Virol; 1994 Sep; 44(1):104-9. PubMed ID: 7798879 [Abstract] [Full Text] [Related]
39. Higher human T lymphotropic virus (HTLV) provirus load is associated with HTLV-I versus HTLV-II, with HTLV-II subtype A versus B, and with male sex and a history of blood transfusion. Murphy EL, Lee TH, Chafets D, Nass CC, Wang B, Loughlin K, Smith D, HTLV Outcomes Study Investigators. J Infect Dis; 2004 Aug 01; 190(3):504-10. PubMed ID: 15243924 [Abstract] [Full Text] [Related]
40. Stable human T-cell lymphotropic virus type 1 (HTLV-1) subtype a/subgroup a endemicity in Amerindians from Northwest Argentina: a health problem to be resolved. Eirin ME, Berini CA, Jones LR, Dilernia DA, Puca AA, Biglione MM. J Med Virol; 2010 Dec 01; 82(12):2116-22. PubMed ID: 20981802 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]